Advances in the diagnosis and treatment of medullary thyroid carcinoma.

L. M. Brunt; S. A. Wells

doi:10.1016/S0039-6109(16)44183-6

Advances in the diagnosis and treatment of medullary thyroid carcinoma.

L. M. Brunt, S. A. Wells

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Abstract

Medullary thyroid carcinoma accounts for 5 to 10 per cent of all thyroid malignancies and may occur in a familial or a sporadic pattern. This article reviews the authors' experience with 200 patients with medullary thyroid carcinoma and outlines the recent advances made in our understanding of the biochemical properties of these cancer cells and the relationship of different tumor markers to prognosis.

Original language	English
Pages (from-to)	263-279
Number of pages	17
Journal	The Surgical clinics of North America
Volume	67
Issue number	2
DOIs	https://doi.org/10.1016/S0039-6109(16)44183-6
State	Published - Apr 1987

Access to Document

10.1016/S0039-6109(16)44183-6

Cite this

@article{c4ea420264284c40985ba6681e33097f,

title = "Advances in the diagnosis and treatment of medullary thyroid carcinoma.",

abstract = "Medullary thyroid carcinoma accounts for 5 to 10 per cent of all thyroid malignancies and may occur in a familial or a sporadic pattern. This article reviews the authors' experience with 200 patients with medullary thyroid carcinoma and outlines the recent advances made in our understanding of the biochemical properties of these cancer cells and the relationship of different tumor markers to prognosis.",

author = "Brunt, {L. M.} and Wells, {S. A.}",

year = "1987",

month = apr,

doi = "10.1016/S0039-6109(16)44183-6",

language = "English",

volume = "67",

pages = "263--279",

journal = "The Surgical clinics of North America",

issn = "0039-6109",

number = "2",

}

TY - JOUR

T1 - Advances in the diagnosis and treatment of medullary thyroid carcinoma.

AU - Brunt, L. M.

AU - Wells, S. A.

PY - 1987/4

Y1 - 1987/4

N2 - Medullary thyroid carcinoma accounts for 5 to 10 per cent of all thyroid malignancies and may occur in a familial or a sporadic pattern. This article reviews the authors' experience with 200 patients with medullary thyroid carcinoma and outlines the recent advances made in our understanding of the biochemical properties of these cancer cells and the relationship of different tumor markers to prognosis.

AB - Medullary thyroid carcinoma accounts for 5 to 10 per cent of all thyroid malignancies and may occur in a familial or a sporadic pattern. This article reviews the authors' experience with 200 patients with medullary thyroid carcinoma and outlines the recent advances made in our understanding of the biochemical properties of these cancer cells and the relationship of different tumor markers to prognosis.

UR - http://www.scopus.com/inward/record.url?scp=0023324015&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(16)44183-6

DO - 10.1016/S0039-6109(16)44183-6

M3 - Article

C2 - 2882613

AN - SCOPUS:0023324015

SN - 0039-6109

VL - 67

SP - 263

EP - 279

JO - The Surgical clinics of North America

JF - The Surgical clinics of North America

IS - 2

ER -

Advances in the diagnosis and treatment of medullary thyroid carcinoma.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this